These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2989666

  • 1. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
    McGrath KM, Thomas KB, Herrington RW, Turner PJ, Taylor L, Ekert H, Schiff P, Gust ID.
    Med J Aust; 1985 Jul 08; 143(1):11-3. PubMed ID: 2989666
    [Abstract] [Full Text] [Related]

  • 2. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.
    Goedert JJ, Sarngadharan MG, Eyster ME, Weiss SH, Bodner AJ, Gallo RC, Blattner WA.
    Blood; 1985 Feb 08; 65(2):492-5. PubMed ID: 2981592
    [Abstract] [Full Text] [Related]

  • 3. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JK, Dixon G, Doxey M, Evatt BL.
    JAMA; 1985 Jun 21; 253(23):3409-15. PubMed ID: 2987559
    [Abstract] [Full Text] [Related]

  • 4. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL, Jason JM, Ramsey RB, Lechner K, Pabinger-Fasching I, Kalyanaraman VS, McDougal JS, Cabradilla CD, Tregillus LC, Lawrence DN.
    Thromb Haemost; 1985 Apr 22; 53(2):180-2. PubMed ID: 2992112
    [Abstract] [Full Text] [Related]

  • 5. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK, Kitchen LW, Prince HE, Kasper CK, Goldstein AL, Naylor PH, Preble O, Stewart JA, Essex M.
    Am J Med; 1986 Mar 22; 80(3):345-50. PubMed ID: 3006485
    [Abstract] [Full Text] [Related]

  • 6. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
    Heimburger N, Karges HE, Weidmann E.
    Dev Biol Stand; 1987 Mar 22; 67():303-10. PubMed ID: 3038638
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hemophilia and HTLV-III infection].
    Lechler E.
    Z Hautkr; 1986 Dec 01; 61(23):1687-704. PubMed ID: 2949442
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The acquired immunodeficiency syndrome in persons with hemophilia.
    Levine PH.
    Ann Intern Med; 1985 Nov 01; 103(5):723-6. PubMed ID: 2996407
    [Abstract] [Full Text] [Related]

  • 15. AIDS and haemophilia: morbidity and morality in a well defined population.
    Jones P, Hamilton PJ, Bird G, Fearns M, Oxley A, Tedder R, Cheingsong-Popov R, Codd A.
    Br Med J (Clin Res Ed); 1985 Sep 14; 291(6497):695-9. PubMed ID: 2994801
    [Abstract] [Full Text] [Related]

  • 16. Concentrate safety and efficacy.
    Kasper CK.
    Haemophilia; 2002 May 14; 8(3):161-5. PubMed ID: 12010404
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.